Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth & Healthcare Conference

SAN DIEGO, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. CYTX announced today that it will present at the 2^nd Annual Disruptive Growth & Healthcare Conference at 11:15 AM Eastern Time (8:15 AM Pacific Time) on Wednesday, February 15, 2017. The presentation will take place in the Track 3 - Nolita room at the Convene in New York City. Dr. Marc Hedrick, CEO and President of Cytori Therapeutics, will provide an update on current corporate activities and recent developments. For those interested in attending, please visit www.DisruptNYC.com for more information.

A live audio and video webcast of the presentation will be available under the investor relations section of Cytori's website at www.cytori.com (http://ir.cytori.com).  A replay of the presentation will be available for 90 days following the event. Please connect to Cytori's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Cytori Therapeutics

Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori's proprietary technologies and products. For more information: visit www.cytori.com. 

Cytori Therapeutics, Inc.
Tiago Girao, +1 (858) 458.0900
ir@cytori.com